CPH.AX - Creso Pharma Limited

ASX - ASX Delayed Price. Currency in AUD
0.2900
-0.0050 (-1.69%)
At close: 4:10PM AEDT
Stock chart is not supported by your current browser
Previous Close0.2950
Open0.3000
Bid0.2900 x 0
Ask0.2950 x 0
Day's Range0.2900 - 0.3000
52 Week Range0.2850 - 0.6200
Volume168,996
Avg. Volume178,893
Market Cap43.948M
Beta (3Y Monthly)3.22
PE Ratio (TTM)N/A
EPS (TTM)-0.1110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Latest Developments Highlight Why It’s Time to Buy PharmaCielo (TSXV:PCLO)
    The Motley Fool

    Latest Developments Highlight Why It’s Time to Buy PharmaCielo (TSXV:PCLO)

    Get ready for PharmaCielo Ltd. (TSXV:PCLO) to soar as commercial production nears.

  • PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
    CNW Group

    PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts

    TORONTO and RIONEGRO, Colombia, Aug. 1, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is ramping up its oil processing capabilities in the Company's Rionegro, Colombia facility following the recent acquisition and installation of additional high-performance, high-volume extractors, combined with proprietary extraction techniques.

  • CNW Group

    Horizons ETFs Rebalances Marijuana-Focused ETFs

    TORONTO , July 3, 2019 /CNW/ - Horizons ETFs Management (Canada ) Inc. (" Horizons ETFs ") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences ...

  • Want to Cash in on the Marijuana Boom? My Top Cannabis Stock to Buy in June
    The Motley Fool

    Want to Cash in on the Marijuana Boom? My Top Cannabis Stock to Buy in June

    Buy Colombian cannabis cultivator PharmaCielo Ltd. (TSXV:PCLO) today before it soars.

  • PharmaCielo Announces Trading on the OTC Market
    CNW Group

    PharmaCielo Announces Trading on the OTC Market

    TORONTO and RIONEGRO, Colombia, June 21, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO) (OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that it is trading on the OTC Markets under the symbol "PHCEF". "With our recently announced acquisition agreement with Creso Pharma (ASX:CPH.AX - News) there is increased attention and interest in our stock. Trading on the OTC will increase access for U.S. and international investors, providing greater liquidity and better access to capital. As we move forward building a global medicinal cannabis company, we will work to provide easy access and liquidity for investors in all jurisdictions," said David Attard, Chief Executive Officer of PharmaCielo Ltd.

  • PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
    CNW Group

    PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million

    TORONTO, June 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced that it has entered into a scheme implementation agreement (the "Implementation Agreement") pursuant to which PharmaCielo has agreed to acquire all of the issued and outstanding shares and listed options of Creso Pharma Ltd. ("Creso Pharma") (ASX:CPH.AX - News), for an aggregate purchase price of approximately A$122 million (the "Acquisition").  Creso Pharma is a global medicinal cannabis company that specializes in research, development and production of therapeutic, nutraceutical and animal health products. PharmaCielo will pay A$0.63 per Creso Pharma share, representing a premium of 50% over the closing trading price of the Creso Pharma shares on May 31, 2019.

  • GlobeNewswire

    Creso Looks to Capitalize on Domestic & Foreign Legislation -- CFN Media

    SEATTLE, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Inc. (ASX:CPH), new legislation, and how it aims to become one of the world’s most trusted suppliers of cannabis and hemp-derived products by combining pharmaceutical rigor, good manufacturing practices (GMP) standards, and proprietary delivery technologies. The cannabis industry is driven primarily by legislation—whether it’s the legalization of adult-use cannabis across a growing number of countries or more nuanced legal moves. Over the past few months, two pieces of legislation could have a significant impact on the global cannabis industry: The passage of the 2018 Farm Bill in the United States and the legalization of medical cannabis exports in Israel.

  • GlobeNewswire

    Creso Pharma Brings Together Cannabis Experts Across Several Verticals-- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH), a small-cap company founded in 2016 that has amassed one of the most experienced management teams in the cannabis industry. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management team above all else. In this article, we will take a closer look at the company’s management team and advisory board, as well as how their expertise have helped drive progress.

  • GlobeNewswire

    Creso Pharma: A Truly Global Cannabis Company-- CFN Media

    SEATTLE, Dec. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma’s (ASX:CPH) innovative approach, diverse product portfolio, and why investors may want to take a closer look as it gears up to go public on the Venture exchange in Canada. The listing would make Creso the first public cannabis company listed in both Australia and Canada. The North American cannabis industry is littered with companies touting global ambitions.